COMMUNIQUÉS West-GlobeNewswire

Olympia Pharmaceuticals Launches OlympiaYou.com: Empowering Patients Through Innovative Wellness and Sexual Health Support
24/06/2025
New platform brings erectile dysfunction, weight loss, and wellness support directly to individuals through virtual pharmacist care and nationwide delivery ORLANDO, Fla., June 24, 2025 (GLOBE NEWSWIRE) -- Olympia [...]
Rebirth Globe Launches Global Expansion Across the Americas and Middle East, Welcomes International Medical Expert Miss Lucy Yang
24/06/2025
Global expansion into the Americas and Middle East fuels Rebirth Globe’s $15M growth projection for 2025 Rebirth Logo NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Rebirth Globe, a pioneering leader in advanced aesthetic [...]
Peter Gilgan investing $60 million to build extraordinary at St. Joseph's Health Centre
24/06/2025
Building Home of Extraordinary: Gilgan provides historic gift for state-of-the-art patient tower PETER GILGAN GIVES DEEPLY PERSONAL GIFT TO ST. JOE’S TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Peter Gilgan, founder and [...]
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
24/06/2025
The future of fracture fixation with novel side-specific nails featuring variable angle locking technology Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its new [...]
Bioma Probiotics Launches to Address Weight Loss through Microbiome and Digestive Balance
24/06/2025
Explore the science behind Bioma probiotics and their impact on gut health, metabolism, and weight loss management. Understand how your digestive system influences weight regulation and energy levels, and discover user [...]
BioAdaptives Announces National Launch of Pawpa™ Regen
24/06/2025
Revolutionary Canine Supplement Promotes Regenerative Healing Through Stem Cell Activation LAS VEGAS , June 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC Pink: BDPT), an innovator in nutraceutical and [...]
Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine
24/06/2025
Cette collaboration permet la réalisation de tests de détection des impuretés de nitrosamine offrant aux promoteurs la possibilité de démontrer l’utilisation acceptable de la rifampicine dans les études sur les [...]
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
24/06/2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]
Le Dr Mark Kirchhof nommé président de l’Association canadienne de dermatologie
24/06/2025
OTTAWA, 24 juin 2025 (GLOBE NEWSWIRE) -- L’Association canadienne de dermatologie (ACD) est fière d’annoncer la nomination du Dr Mark Kirchhof au poste de président de l’ACD. Il assumera ses fonctions à compter du 19 [...]
Dr. Mark Kirchhof appointed President of the Canadian Dermatology Association
24/06/2025
OTTAWA, June 24, 2025 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) is pleased to announce the appointment of Dr. Mark Kirchhof as CDA President, effective June 19, 2025. Dr. Mark Kirchhof is a [...]
Longeveron® Announces Completion of Enrollment of Pivotal Phase 2b Clinical Trial Evaluating Laromestrocel as a Treatment for Hypoplastic Left Heart Syndrome (HLHS)
24/06/2025
Top-line trial results are anticipated in the third quarter of 2026, after the final follow-up at 12-months Laromestrocel Biological License Application (BLA) submission for full traditional approval for HLHS [...]
Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
24/06/2025
-- Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive Cash Flow -- -- Conference Call Today at 8:00 a.m. EDT with [...]
Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema
24/06/2025
MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the [...]
Revolution Medicines Enters Into $2 Billion Flexible Funding Agreement with Royalty Pharma to Support Global Development and Commercialization of RAS(ON) Inhibitor Portfolio for Patients with RAS-Addicted Cancers
24/06/2025
Flexible funding provides $2 billion in committed capital comprised of up to $1.25 billion of synthetic royalty and up to $750 million in corporate debt Company moving forward with independent global commercialization [...]
Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use
24/06/2025
SAVONA, Italy, June 24, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance [...]
Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction
24/06/2025
Transaction Follows Completion of Comprehensive Strategic Review by Special Committee of the Board to Maximize Shareholder Value Farmingdale, NY, June 24, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo [...]
Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
24/06/2025
Intra-patient, double-blind, multicenter, placebo-controlled study with crossover design Repeat administration under compassionate use was previously shown to be well tolerated and associated with full corneal healing [...]
Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum
24/06/2025
Dr. Kris Radcliff to Highlight MR Spectroscopy and Augmented Intelligence (AI)-Based Platform at State of Spine Surgery Think Tank BROOMFIELD, Colo., June 24, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the [...]
Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America
24/06/2025
C-FORWARD is the Second Phase 3 Trial in the Global HCV Development Program; the First Phase 3 Trial, C-BEYOND, is Currently Enrolling Patients in the US and Canada Regimen has Potential Best-in-Class Profile with Short [...]

Pages